{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:03:53Z","timestamp":1791216233047,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004700","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T00:00:00Z","timestamp":1098057600000}}],"reference-count":30,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004700.pub2","type":"journal-article","created":{"date-parts":[[2005,1,17]],"date-time":"2005-01-17T02:17:13Z","timestamp":1105928233000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Early versus late chest radiotherapy in patients with limited-stage small cell lung cancer"],"prefix":"10.1002","volume":"2010","author":[{"given":"Madelon","family":"Pijls-Johannesma","sequence":"first","affiliation":[{"name":"GROW-School for Oncology and Developmental Biology; Department of Radiation Oncology (MAASTRO); Maastricht University Medical Centre Maastricht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk K M","family":"De Ruysscher","sequence":"additional","affiliation":[{"name":"GROW-School for Oncology and Developmental Biology; Department of Radiation Oncology (MAASTRO); Maastricht University Medical Centre Maastricht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lambin","sequence":"additional","affiliation":[{"name":"GROW-School for Oncology and Developmental Biology; Department of Radiation Oncology (MAASTRO); Maastricht University Medical Centre Maastricht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud","family":"Houben","sequence":"additional","affiliation":[{"name":"GROW-School for Oncology and Developmental Biology; Department of Radiation Oncology (MAASTRO); Maastricht University Medical Centre Maastricht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rutten","sequence":"additional","affiliation":[{"name":"University Hospital of Li\u00e8ge, Belgium; Radiotherapy; Domaine Universitaire du Sart Tilman, Batiment B 35 Liege Belgium 4000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan F.","family":"Vansteenkiste","sequence":"additional","affiliation":[{"name":"University Hospital Gasthuisberg, Belgium; Respiratory Oncology Unit; Herestraat 49 Leuven Belgium 3000"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,10,18]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD004700.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.1997.15.3.893","article-title":"Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study","volume":"15","author":"Jeremic","year":"1997","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD004700.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1200\/JCO.1993.11.2.336","article-title":"Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group","volume":"11","author":"Murray","year":"1993","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD004700.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1200\/JCO.1998.16.7.2466","article-title":"Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083","volume":"16","author":"Perry","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD004700.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1023\/A:1012295131640","article-title":"Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)","volume":"12","author":"Skarlos","year":"2001","journal-title":"Annals of Oncology"},{"issue":"24","key":"10.1002\/14651858.CD004700.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1200\/JCO.2005.05.3181","article-title":"Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized trial and meta-analysis","volume":"24","author":"Spiro","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"14","key":"10.1002\/14651858.CD004700.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1200\/JCO.2002.12.071","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104","volume":"20","author":"Takada","year":"2002","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD004700.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1200\/JCO.1997.15.9.3030","article-title":"Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group","volume":"15","author":"Work","year":"1997","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD004700.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3816\/CLC.2005.n.007","article-title":"Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial","volume":"6","author":"Blackstock","year":"2005","journal-title":"Clinical Lung Cancer"},{"issue":"9","key":"10.1002\/14651858.CD004700.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1200\/JCO.1999.17.9.2681","article-title":"Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma","volume":"17","author":"Bonner","year":"1999","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD004700.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1200\/JCO.1997.15.8.2840","article-title":"Randomized trial of alternating versus sequential radiotherapy\/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study","volume":"15","author":"Gregor","year":"1997","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD004700.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1480::AID-CNCR14>3.0.CO;2-O","article-title":"A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma","volume":"86","author":"Lebeau","year":"1999","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD004700.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199901283400403","article-title":"Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide","volume":"340","author":"Turrisi","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD004700.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJM199908123410703","article-title":"Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission","volume":"341","author":"Auperin","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004700.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0167-8140(91)90019-D","article-title":"Clinical evidence for tumor clonogen regeneration: interpretations of the data","volume":"22","author":"Bentzen","year":"1991","journal-title":"Radiotherapy and Oncology"},{"issue":"2 Suppl 7","key":"10.1002\/14651858.CD004700.pub2-BIB0015|cit15","first-page":"69S","article-title":"Overview of chemotherapy for small cell lung cancer","volume":"24","author":"Bunn","year":"1997","journal-title":"Seminars in Oncology"},{"key":"10.1002\/14651858.CD004700.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1470-2045(00)00019-X","article-title":"Repopulation of tumor cells between cycles of chemotherapy: a neglected factor","volume":"1","author":"Davis","year":"2000","journal-title":"The Lancet Oncology"},{"issue":"1","key":"10.1002\/14651858.CD004700.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8140(00)00156-0","article-title":"Chest radiotherapy in limited-stage small cell lung cancer: facts, questions, prospects","volume":"55","author":"Ruysscher","year":"2000","journal-title":"Radiotherapy and Oncology"},{"issue":"7","key":"10.1002\/14651858.CD004700.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1200\/JCO.2005.02.9793","article-title":"Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer","volume":"24","author":"Ruysscher","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD004700.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/srao.2003.50001","article-title":"Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors","volume":"13","author":"Harari","year":"2003","journal-title":"Seminars in Radiation Oncology"},{"key":"10.1002\/14651858.CD004700.pub2-BIB0020|cit20","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD004700.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"243S","DOI":"10.1378\/chest.107.6_Supplement.243S","article-title":"Small cell lung cancer. State-of-the-art therapy 1994","volume":"107","author":"Ihde","year":"1995","journal-title":"Chest"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD004700.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"156S","DOI":"10.1378\/chest.117.4_suppl_1.156S","article-title":"New chemotherapy agents for small cell lung cancer","volume":"117","author":"Kelly","year":"2000","journal-title":"Chest"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD004700.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"259S","DOI":"10.1378\/chest.112.4_Supplement.259S","article-title":"The role of thoracic radiotherapy in the management of limited-stage small cell lung cancer: past, present, and future","volume":"112","author":"Kumar","year":"1997","journal-title":"Chest"},{"issue":"23","key":"10.1002\/14651858.CD004700.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199212033272302","article-title":"A meta-analysis of thoracic radiotherapy for small-cell lung cancer","volume":"327","author":"Pignon","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004700.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ctrv.2007.03.002","article-title":"Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials","volume":"33","author":"Pijls-Johannesma","year":"2007","journal-title":"Cancer Treatment Reviews"},{"issue":"16","key":"10.1002\/14651858.CD004700.pub2-BIB0026|cit26","first-page":"1","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"2","key":"10.1002\/14651858.CD004700.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0959-8049(01)00364-1","article-title":"The treatment of limited small cell lung cancer: a report of the progress made and future prospects","volume":"38","author":"Turrisi","year":"2002","journal-title":"European Journal of Cancer"},{"issue":"6","key":"10.1002\/14651858.CD004700.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.1992.10.6.890","article-title":"Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis","volume":"10","author":"Warde","year":"1992","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD004700.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogen repopulation during radiotherapy","volume":"27","author":"Withers","year":"1988","journal-title":"Acta Oncologica (Stockholm, Sweden)"},{"issue":"1","key":"10.1002\/14651858.CD004700.pub2-BIB0030|cit30","article-title":"Early versus late chest radiotherapy in patients with limited stage small cell lung cancer","author":"Pijls-Johannesma","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004700.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:19:55Z","timestamp":1764548395000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004700.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Lung Cancer Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2004,10,18]]},"references-count":30,"aliases":["10.1002\/14651858.cd004700"],"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004700.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,18]]}}}